Work

OP 2.1 CCR5 in HIV Prevention and Cure

Year: 2022

Type: article

Abstract: years from an estimated epigenetic age of 42.8 years at baseline to 27.7 years at week 24 and 29.2 years at week 48.Additionally, this participant showed a decrease in epigenetic mortality risk and increased inferred telomere length.Conclusions: Multimodal curative interventions in PLWH do not accelerate epigenetic biomarkers of aging, mortality risk, and pace of aging.Findings from the São Paulo patient suggest that potential interventions that lead to a reversal of epigenetic age may determine rebound delay.

Source: Journal of Virus Eradication

DOI: 10.1016/j.jve.2022.100149

Authors: Helen L. Wu, Gabriela M. Webb, Jonah B. Sacha

Institutions: Oregon National Primate Research Center, Oregon Health & Science University

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,950